Skip to Main Content

Author Details

Phillip A Futreal
The University of Texas MD Anderson Cancer Center
1991
406
124
PMIDPaper TitleJournal TitlePublished Year
37806335ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma.Ann Thorac Surg2024
36166093Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.Clin Cancer Res2023
37804122Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA).Pigment Cell Melanoma Res2023
37593416Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma.HGG Adv2023
37961165A novel Bayesian model for assessing intratumor heterogeneity of tumor infiltrating leukocytes with multi-region gene expression sequencing.bioRxiv2023
37479893Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance.Commun Biol2023
37586362Archival single-cell genomics reveals persistent subclones during DCIS progression.Cell2023
37786705Evolutionary fingerprints of EMT in pancreatic cancers.bioRxiv2023
37503252Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.Res Sq2023
37419119Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.Cancer Cell2023
37285177Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.Cancer Immunol Res2023
36988276Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes.Clin Cancer Res2023
37248301Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.Nat Med2023
37449360Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.Clin Cancer Res2023
37311413Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.Cancer Cell2023
37443196T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.Leukemia2023
37465976Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant Therapy.Ann Surg2023
37068116Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors.Mol Cancer Res2023
37095322PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.Nat Cell Biol2023
37163233Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.Cancer Immunol Res2023
37063829HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development.Front Immunol2023
36788067Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.Mod Pathol2023
36689729TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm.Blood Adv2023
36607962Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.PLoS One2023
36703611Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing.Mol Oncol2023
36627494Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2023
34135465Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.Leukemia2022
35512188Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.Blood2022
35411096Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib.Leukemia2022
35650195The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma.Nat Commun2022
35546239Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma.J Exp Clin Cancer Res2022
35379887Multi-site desmoplastic small round cell tumors are genetically related and immune-cold.NPJ Precis Oncol2022
35705814Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2022
35792683Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.Cancer2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
35533245Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma.Blood Cancer Discov2022
35389428Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical Trial.JAMA Oncol2022
35449104The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021.J Transl Med2022
35810190Multi-modal molecular programs regulate melanoma cell state.Nat Commun2022
35618837A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.Nat Med2022
35413951Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.Nat Commun2022
36477537Structural variants drive context-dependent oncogene activation in cancer.Nature2022
36528667Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.J Transl Med2022
35934010Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.Lancet Oncol2022
36239936Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.JAMA Netw Open2022
36202798Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF<sup>V600E</sup> inhibition resistance in melanoma.Cell Discov2022
36098652The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.Cancer Discov2022
36303017Netie: inferring the evolution of neoantigen-T cell interactions in tumors.Nat Methods2022
36201462Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy.PLoS One2022
35892848Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer.Cancers (Basel)2022
  • 1 - 50 of 406

Recommended Authors

Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 17
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 56
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 65
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 25
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 48
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 15
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 23
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 4
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 57
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 22
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 12
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 107
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 3
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 27
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 9
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 77
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 8
Barbara A Weir
Janssen Research and Development LLC
Career Start Year 1997
Number of shared co-authors 32
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 60
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 17
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 22
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 9
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 12
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 44
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 20
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 66
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 106
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 20

Collaborators

Michael R Stratton
Wellcome Sanger Institute
Co-authored papers 106
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Co-authored papers 84
Adam Butler
Wellcome Sanger Institute
Co-authored papers 56
Jon Teague
Wellcome Sanger Institute
Co-authored papers 56
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 46
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 46
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Co-authored papers 46
Patrick S Tarpey
Wellcome Trust Sanger Institute
Co-authored papers 44
Andrew Menzies
Wellcome Sanger Institute
Co-authored papers 43
Sarah Edkins
Co-authored papers 41
Xingzhi Song
The University of Texas MD Anderson Cancer Center
Co-authored papers 40
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 33
Chris Greenman
University of East Anglia
Co-authored papers 33
David Jones
Wellcome Sanger Institute
Co-authored papers 32
Guillermo Garcia-Manero
MD Anderson Cancer Center
Co-authored papers 32
Sarah O'Meara
Clinical Research Facility, Mercy University Hospital
Co-authored papers 31
Jennifer A Wargo
Co-authored papers 29
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 28
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 26
Laura Mudie
Wellcome Trust Sanger Institute
Co-authored papers 22
Linghua Wang
The University of Texas M. D. Anderson
Co-authored papers 22
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers 21
Rebecca Shepherd
Murdoch Children's Research Institute, Royal Children's Hospital
Co-authored papers 21
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 21
Jonathan Hinton
Inivata Ltd
Co-authored papers 21
Douglas F Easton
University of Cambridge
Co-authored papers 20
Peter Van Loo
The Francis Crick Institute
Co-authored papers 19
Lucy A Stebbings
Wellcome Trust Sanger Institute
Co-authored papers 19
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers 19
Stuart McLaren
Wellcome Trust Sanger Institute
Co-authored papers 19
Release 1.2